Lund Melanoma Study Group
61 – 70 of 250
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Dialysis as a Novel Adjuvant Treatment for Malignant Cancers
- Contribution to journal › Scientific review
-
Mark
DNA promoter hypermethylation of melanocyte lineage genes determines melanoma phenotype
- Contribution to journal › Article
-
Mark
Interplay between Caveolin-1 and body and tumor size affects clinical outcomes in breast cancer
- Contribution to journal › Article
-
Mark
B Cells and Tertiary Lymphoid Structures : Friends or Foes in Cancer Immunotherapy?
- Contribution to journal › Scientific review
-
Mark
Systematic review of low-income and middle-income country perceptions of visiting surgical teams from high-income countries
- Contribution to journal › Scientific review
-
Mark
Therapeutic Value of Sentinel Lymph Node Biopsy in Patients With Melanoma: A Randomized Clinical Trial
- Contribution to journal › Article
-
Mark
Copy number variants are ovarian cancer risk alleles at known and novel risk loci
- Contribution to journal › Article
-
Mark
Distinct Reproductive Risk Profiles for Intrinsic-Like Breast Cancer Subtypes : Pooled Analysis of Population-Based Studies
- Contribution to journal › Article
- 2021
-
Mark
Pre- and Postoperative Circulating IGF-I, IGFBP-3, and IGFBP-7 Levels in Relation to Endocrine Treatment and Breast Cancer Recurrence : A Nested Case-Control Study
- Contribution to journal › Article
-
Mark
Combined presentation and immunogenicity analysis reveals a recurrent RAS.Q61K neoantigen in melanoma
- Contribution to journal › Article
